GCM
COCH icon

Ghisallo Capital Management’s Envoy Medical COCH Stock Holding History

Ghisallo Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-187,498
Closed -$1.89M – 75
2022
Q4 		$1.89M Sell
187,498
-2
-0% -$20 0.34% 68
2022
Q3 		$1.84M Hold
187,500
– – 0.25% 161
2022
Q2 		$1.84M Hold
187,500
– – 0.23% 161
2022
Q1 		$1.83M Hold
187,500
– – 0.2% 194
2021
Q4 		$1.83M Hold
187,500
– – 0.09% 303
2021
Q3 		$1.82M Hold
187,500
– – 0.07% 314
2021
Q2 		$1.82M Buy
+187,500
New +$1.82M 0.07% 317

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ghisallo Capital Management's COCH Position: Q1 2023 in Review

Ghisallo Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 187,498 shares — an estimated $1.89M sold.

Ghisallo Capital Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $1.89M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Ghisallo Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Ghisallo Capital Management sold 187,498 Envoy Medical shares in Q1 2023, an estimated $1.89M.
  • Ghisallo Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Ghisallo Capital Management's Envoy Medical position peaked at $1.89M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Ghisallo Capital Management's 13F filing for Q1 2023, filed 15 May 2023.